A study of individuals with tobacco use disorder in China reported that a five-day course of repetitive transcranial magnetic ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Telangana: Drugs Control Administration, Telangana has seized improperly stored Tetanus Vaccine and Oxytocin Injections in ...

Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...

Redistricting claimant, Jeremy Enriquez sought, through an application dated February 21, to have the Court of Appeal overturn the decision of High Court Justice Tawanda Hondora which denied the ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

State Key Laboratory of Natural Medicines, Department of Organic Chemistry, China Pharmaceutical University, Nanjing 210009, China ...

Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

HealthDay News — For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal ...

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for ...

"I think we're all going to be very eager to see what happens to these patients over time," says Colin Goudelocke, MD. In this video, Colin Goudelocke, MD, discusses the significance of the findings ...